Lv1
70 积分 2025-06-30 加入
The evolving landscape of drug targets
27天前
已完结
An intrinsically hydrophilic linker enables a stable, high-DAR exatecan-based HER2 ADC with potent antitumor activity
4个月前
已完结
An intrinsically hydrophilic linker enables a stable, high-DAR exatecan-based HER2 ADC with potent antitumor activity
4个月前
已关闭
One‐Step Assembly of Homogeneous DAR4 ADCs via a Traceless Fc Ligand‐Directed Acylation Strategy
7个月前
已完结
Immune reprogramming of tumor microenvironments by cytotoxic antibody-drug conjugate payloads
10个月前
已完结
Protein Chromatography
11个月前
已关闭
The Power of Creative Destruction
1年前
已关闭
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
1年前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
1年前
已完结
Discovery and Design of Novel Cyclic Peptides as Specific Inhibitors Targeting CCN2 and Disrupting CCN2/EGFR Interaction for Kidney Fibrosis Treatment
1年前
已完结
皖公网安备34019202002308
